Sort   by:  
 Page size 
ProteomicsRET Kinase Inhibition in Neuroendocrine Prostate Cancer, part 2
Increased treatment of metastatic castration resistant prostate cancer (mCRPC) with second-generation anti-androgen therapies (ADT) has coincided with a greater incidence of lethal, aggressive variant prostate cancer (AVPC) tumors that have lost androgen receptor (AR) signaling. AVPC tumors may also...
ORGANISM(S): Homo sapiens (Human) 
2020-05-29 | PXD012971 | Pride
Human Kinase Phosphoproteomics Prostate cancer Ret 
ProteomicsRET Kinase Inhibition in Neuroendocrine Prostate Cancer, part 1
Increased treatment of metastatic castration resistant prostate cancer (mCRPC) with second-generation anti-androgen therapies (ADT) has coincided with a greater incidence of lethal, aggressive variant prostate cancer (AVPC) tumors that have lost androgen receptor (AR) signaling. AVPC tumors may also...
ORGANISM(S): Homo sapiens (Human) 
2020-05-29 | PXD012970 | Pride
Ret Prostate cancer Kinase Phosphoproteomics 
ProteomicsThe proteome landscape of extracellular vesicles from prostate cancer cell lines
Proteome of extracellular vesicles (EVs) collected from prostate cancer cell lines - LNCaP, 22RV1, LNCaP 95, C4-2, DU145, PC3, NCI-H660, LASCPC-01, EF1.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2024-11-25 | MSV000096519 | MassIVE
Sort   by:  
 Page size